IGL Spirits H1 FY27 Revenue Rises 14.3% to Rs 4,837 Cr After Demerger
IGL Spirits Limited posted revenue from operations of Rs 4,837.30 crore for H1 FY27, up 14.3% year-on-year, in its first results since the spirits and biofuel undertaking was demerged from India Glycols. Profit after tax rose to Rs 120.79 crore, while EBITDA grew only 2.6%, indicating thinner operating margins.

Key takeaways
- H1 FY27 revenue from operations rose 14.3% to Rs 4,837.30 crore; Q2 revenue was up 10.3% at Rs 2,295.41 crore.
- Q2 FY27 EBITDA was nearly flat at Rs 124.68 crore versus Rs 124.59 crore a year earlier.
- H1 FY27 PAT was Rs 120.79 crore against Rs 112.40 crore; Q2 PAT was Rs 61.20 crore.
- These are the first results after the demerger from India Glycols, with prior-period figures restated.
- The NCLT approved the scheme on July 17, 2026, with an appointed date of April 1, 2026.
IGL Spirits Limited has reported a 14.3 per cent year-on-year rise in half-yearly revenue from operations to Rs 4,837.30 crore for H1 FY27, in its first quarterly and half-yearly results since the spirits and biofuel undertaking was demerged from India Glycols Limited. While sales grew at a healthy pace and profit after tax (PAT) moved higher, operating profit growth was far slower than the top line.
What happened: Q2 FY27 numbers
The Noida-based company announced unaudited results for the quarter and half year ended September 30, 2026. For Q2 FY27, the key figures were as follows (all in Rs crore):
- Revenue from operations: 2,295.41, against 2,080.63 in Q2 FY26, a rise of 10.3 per cent.
- EBITDA: 124.68, against 124.59 a year earlier, essentially flat.
- PAT: 61.20, against 57.56, an increase of about 6.3 per cent.
- Quarterly EPS: Rs 9.13, against Rs 8.59.
H1 FY27 performance
For the six months ended September 30, 2026, the company reported the following (in Rs crore):
- Revenue from operations: 4,837.30, compared with 4,233.26 in H1 FY26, up 14.3 per cent.
- EBITDA: 244.78, compared with 238.46, up 2.6 per cent.
- PAT: 120.79, compared with 112.40, an increase of roughly 7.5 per cent.
- Half-yearly EPS: Rs 18.02, compared with Rs 16.77.
Why it matters for investors
The headline growth in sales is clear, but the profitability picture is more measured. Based on the reported figures, EBITDA as a share of revenue works out to roughly 5.4 per cent in Q2 FY27, compared with about 6.0 per cent in Q2 FY26. For the half year, the ratio is about 5.1 per cent, against about 5.6 per cent a year earlier. In other words, revenue grew faster than operating profit, so the operating margin narrowed.
PAT grew faster than EBITDA, which suggests that items below the operating line, such as depreciation, finance costs or tax, were relatively more favourable. The source release does not break these items down, so the reasons for the difference cannot be stated with certainty. PAT margin is around 2.7 per cent in Q2 FY27 and about 2.5 per cent for H1 FY27, slightly below the roughly 2.8 per cent and 2.7 per cent recorded in the corresponding periods last year.
The release also does not provide a segment-wise split between spirits and biofuel, nor does it explain what drove the revenue growth, such as volumes, pricing or product mix. Investors looking for that detail will need to consult the company's detailed filings and investor presentations.
Background: the demerger from India Glycols
The results follow a scheme of arrangement under which India Glycols Limited, referred to as the Demerged Company, has been split into separate entities. According to the company's note, the National Company Law Tribunal (NCLT) approved the scheme through an order dated July 17, 2026. Under the scheme, the biopharma undertaking goes to Ennature Bio Pharma Limited, while the spirits and biofuel undertaking goes to IGL Spirits Limited, both on a going-concern basis.
The order was filed with the Registrar of Companies on September 1, 2026. All assets and liabilities of the spirits and biofuel undertaking were transferred to and vested in IGL Spirits with effect from the appointed date of April 1, 2026.
How the accounts have been prepared
IGL Spirits has given accounting effect to the scheme in line with the treatment prescribed in the scheme itself and Appendix C of Ind AS 103, which deals with business combinations of entities under common control. Generally, in such cases the transferred business is accounted for as if it had always been part of the receiving entity. That is why the company says the comparative figures for earlier quarters and the year have been restated to reflect the scheme.
For readers, this means the year-on-year comparisons in the release, such as Rs 4,233.26 crore of H1 FY26 revenue, are on a like-for-like basis for the demerged business rather than being the reported numbers of the former parent. It is also the reason the company describes these as its first comparative results.
Management comment
Manoj Kumar Rai, Executive Director and Chief Operating Officer of IGL Spirits, described the demerger as a pivotal milestone in the company's strategic evolution that sharpens its focus across the spirits and biofuel businesses. He said the company is committed to expanding its market leadership, driving operational excellence and capturing high-value growth opportunities to deliver sustainable, long-term value for stakeholders. The statement did not include specific targets or guidance.
What to watch next
- Operating margins: Whether EBITDA growth begins to keep pace with revenue in coming quarters, after the narrowing seen in Q2 and H1.
- Segment disclosures: Any further breakdown of spirits and biofuel performance, which would help explain the drivers of growth and profitability.
- Standalone identity: How the company reports and communicates as an independent listed entity, including its capital structure, borrowings and dividend approach, none of which are covered in the release.
- Remaining demerger steps: Any updates on the listing or share entitlement formalities connected with the scheme, to be confirmed through exchange filings.
As always, the figures reported are unaudited, and investors should read the full results and notes filed with the stock exchanges before drawing conclusions. This article is for information only and does not constitute investment advice.
Frequently asked questions
What were IGL Spirits' H1 FY27 results?
IGL Spirits reported H1 FY27 revenue from operations of Rs 4,837.30 crore, up 14.3 per cent, EBITDA of Rs 244.78 crore, up 2.6 per cent, and PAT of Rs 120.79 crore against Rs 112.40 crore a year earlier.
How did IGL Spirits perform in Q2 FY27?
Revenue was Rs 2,295.41 crore, up 10.3 per cent. EBITDA was Rs 124.68 crore, almost unchanged from Rs 124.59 crore, and PAT was Rs 61.20 crore compared with Rs 57.56 crore.
Why are these IGL Spirits' first comparative results?
They are the first results after the spirits and biofuel undertaking of India Glycols was demerged into IGL Spirits. The NCLT approved the scheme on July 17, 2026, and prior-period figures have been restated to reflect it.
What is the appointed date of the demerger?
The appointed date is April 1, 2026, from which the assets and liabilities of the spirits and biofuel undertaking vested in IGL Spirits.
What happened to India Glycols' biopharma business?
Under the same scheme, the biopharma undertaking of India Glycols was transferred to Ennature Bio Pharma Limited.
This article is for information only and is not investment advice.